Influence of obstructive sleep apnoea on cardiovascular diseases: Prevalence, occurrence, clinical course, prognosis;Wpływ obturacyjnego bezdechu sennego na choroby sercowo-naczyniowe: Czestość, wystepowanie, przebieg kliniczny, rokowanie

Polski Przeglad Kardiologiczny

Volumn 10, Issue 3, 2008, Pages 231-235

  Uznaánska, Barbara ^a   Kurpesa, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cardiovascular diseases; Obstructive sleep apnoea

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROCARDIOGRAPHY MONITORING; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; OBESITY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PROGNOSIS; PULMONARY HYPERTENSION; RECURRENT DISEASE; RISK REDUCTION; SLEEP APNEA SYNDROME;

EID: 55349103392     PISSN: 15075540     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. de Chazal P, Heneghan C, Sheridan E, i wsp. Automated processing of single-lead electrocardiogram for the detection of obstructive sleep apnoea. IEEE Trans Biomed Eng. 2003;50:686-696.
2. Dursunoglu D, Dursunoglu N. Cardiovascular diseases in obstructive sleep apnea. Tuberk Toraks. 2006;54:382-396.
3. Shamsuzzaman A, Gersh B, Somers V. Obstructive sleep apnea. Implications for cardiac and vascular disease. JAMA. 2003;290:1906-1914.
4. Einhorn D, Steward DA, Erman MK, i wsp. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract. 2007;13:355-362.
5. Young T, Peppard P, Gottlieb D. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165:1217-1239.
6. Narkiewic2 K. Rola układu współczulnego w otiopatogenezie nadciśnienia tetniczego u chorych z obturacyjnym bezdechem podczas snu. W: Narkiewicz K. Układ współczulny a nadciśnienie tetnicze. Gdańsk: Via Medica; 2001. 49-57
7. Peled N, Kassirer M, Shitrit D, i wsp. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med. 2007;101: 1696-1701.
8. Faulx MD, Storfer-Isser A, Kirchner HL, i wsp. Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep. 2007;30:923-929.
9. Gami AS, Rader S, Svatikova A i wsp. Familial premature coronary artery disease mortality and obstructive sleep apnea. Chest, 2007;131:118-121.
10. Dursunoglu D, Dursunoglu N, Evrengül H, i wsp. Impact of obstructive sleep apnoea on left ventricular mass and global function. Eur Respir J. 2005;26:283-288.
11. Shivalkar B, Van de Heyning C, Kerremans M, i wsp. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol. 2006;47:1433-1439.
12. Sanner BM, Doberauer C, Konermann M, i wsp. Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med. 1997;157:2483-2487.
13. Dursunoglu D, Dursunoglu N, Evrengül H, i wsp. QT interval dispersion in obstructive sleep apnoea syndrome patients without hypertension. Eur Respir J. 2005;25:677-681.
14. Yamashita J, Nomura M, Uehara K, i wsp. Influence of sleep apnea on autonomic nervous activity and QT dispersion in patients with essential hypertension and old myocardial infarction. J Electrocardiol. 2004;37:31-40.
15. Harbison J, O'Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome - effects of nasal continuous positive airway pressure therapy. Chest. 2000;118: 591-595.
16. Gami AS, Pressman G, Caples SM, i wsp. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110:364-367.
17. Kanagala R, Murali NS, Friedman PA, i wsp. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589-2594.
18. Mooe T, Rabben T, Wiklund U, i wsp. Sleep-disordered breathing in men with coronary artery disease. Chest. 1996;109:659-663.
19. Mooe T, Rabben T, Wiklund U, I wsp. Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med. 1996;101:251-256.
20. Yumino D, Tsurumi Y, Takagi A, i wsp. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007;99:26-30.
21. Nakashima H, Katayama T, Takagi C, i wsp. Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur Heart J. 2006;27:2317-2322.
22. Cassar A, Morgenthaler TI, Lennon RJ, i wsp. Treatment of obstructive sleep apnea is associated with decreased cardiac death after perculaneous coronary intervention. J Am Coll Cardiol. 2007;50:1310-1314.
23. Mancia G, De Backer G, Dominiczak A, i wsp. 2007 Guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462-1536.
24. Morgan BJ, Dempsey JA, Pegelow DF, i wsp. Blood pressure perturbations caused by subclinical sleep-disordered breathing. Sleep. 1998;21:737-746.
25. Bixler EO, Vgontzas AN, Lin HM, i wsp. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000;160:2289-2295.
26. Drager LF, Bortolotto LA, Figueiredo AC, i wsp. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest. 2007;131:1379-1386.
27. Boström KB, Hedner J, Melander O, i wsp. Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. J Hypertens. 2007;25:779-783.
28. Kaleth AS, Chittenden TW, Hawkins BJ, i wsp. Unique cardiopulmonary exercise test responses in overweight middle-aged adults with obstructive sleep apnea. Sleep. Med. 2007;8:160-168.
29. Dziewas R, Ritter M, Usta N, i wsp. Atherosclerosis and obstructive sleep apnea in patients with ischemic stroke. Cerebrovasc Dis. 2007;24:122-126.
30. Shahar E, Whitney CW, Redline S, i wsp. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19-25.
31. Fischer AQ, Chaudhary BA, Taormina MA, i wsp. Intracranial hemodynamics in sleep apnea. Chest. 1992;102:1402-1406.
32. Steiropoulos P, Tsara V, Nena E, i wsp. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest. 2007;132:843-851.
33. Kaneko Y, Floras JS, Usui K, i wsp. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348:1233-1241.
34. Stanchina ML, Ellison K, Malhotra A, i wsp. The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study. Chest. 2007;132:433-439.